It is noteworthy that none of the melanoma models studied lacked TRAIL-R1/R2 or caspase-8 expression, and TRAIL-Rs or caspase-8 amounts did not appear crucial to predict responsiveness. The gene discussed is TNFRSF10A; the disease is melanoma.